genomics
News,Singapore,Investments,Asia,HealthTech
Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics
Mayo Clinic Laboratories has invested in Singapore-based Pathology Asia Holdings and LifeStrands Genomics to expand advanced diagnostics and precision medicine across Asia Pacific.
September 23, 2026




